With our partners, we are developing faster and less expensive ways of turning laboratory discoveries into new diagnostic tests and treatments for cancer and AIDS.
The National Interagency Confederation for Biological Research (NICBR) announced the 2012 NICBR Collaboration
Project Award (CPA) Program winners in December. The award, the first of its kind for NICBR, was adapted from
the National Cancer Institute’s (NCI’s) Young Investigator Award Program. This year, the CPA was bestowed to three
research projects pertaining to collaborations between NICBR agencies.
in the April edition of The Poster
Balamurugan K., S. Sharan, K.D. Klarmann, Y. Zhang, V. Coppola, G. Summers , T. Roger, D.K. Morrison, J.R. Keller,
and E. Sterneck. FBXW7α attenuates inflammatory
signalling by downregulating C/EBPδ and its target gene Tlr4.
Nature Communications, 4, 1662 doi: 10. 1038/ncooms2677 (2013).
Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, et al. IKK-epsilon coordinates invasion and metastasis of ovarian cancer. Cancer Res
Bjorkstrom NK, Beziat V, Cichocki F, Liu LL, Levine J, Larsson S, et al. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK
cells. Blood 120(17):3455–3465, 2012.
NCI-Frederick has about 3,000 government and contractor employees with a wide range
of expertise in basic, translational, and preclinical research and development in
cancer and AIDS.
Read about some of our recent research advances.
If you have an activity, notice or article that you feel should be featured, we
want to hear about it! Please make your request to the
NCI-Frederick Webmaster and we will do our best to post your information
in the coming months.